GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
TAIPEI, June 2, 2024 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, is showcasing its prowess in artificial intelligence by…
Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
MIAMI BEACH, Fla., June 2, 2024 /PRNewswire/ -- Miami Beach is ready to sizzle this summer with a collection of…
Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
REDWOOD CITY, Calif. , June 2, 2024 /PRNewswire/ -- Rokid, a pioneer in augmented reality (AR) technology, has achieved a significant…
Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
PORT MORESBY, Papua New Guinea, June 2, 2024 /PRNewswire/ -- A team from Pacific Wrecks discovered one of the most…
Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
TAIPEI, June 2, 2024 /PRNewswire/ -- Linker Vision, a pioneer in AI technology, is proud to announce a collaboration with…
ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ -- ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today…
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
TAIPEI, June 2, 2024 /PRNewswire/ -- ASRock Rack Inc., a leading innovative server company, has launched several scale-up servers leveraging…
MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
The PRIMED study found a way to reduce treatment-related side effects among participants, decreasing dose reductions, treatment interruptions, and permanent…
Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
-Trial-in-Progress poster provides overview on PEMDA-HN trial evaluating danvatirsen in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with recurrent/metastatic…
Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
LAGOS, Nigeria, June 2, 2024 /PRNewswire/ -- The Federal Government through the Nigeria Data Protection Commission (NDPC) has granted a…
Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
Results of survey will be presented by Adrian Dobs, M.D., Professor of Medicine and Oncology, The Johns Hopkins School of Medicine, and…
Message from the Governor General on Canadian Environment Week
OTTAWA, ON, June 2, 2024 /CNW/ - Canadian Environment Week is a reminder that we need to take action to protect…
↑